Showing results (121-130 of 190) with videos related to
Sort By:
Pageof 19
Leukemia|November 24, 2019
Correction: Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphomaColleen T Harrington, Elena Sotillo, Aude Robert, et al.Neuro-Oncology|July 17, 2013
Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor studyJacques Grill, Birgit Geoerger, Lyle Gesner, et al.Journal of Neuro-Oncology|December 14, 2017
Outcome of children and adolescents with central nervous system tumors in phase I trialsFernando Carceller, Francisco Bautista, Irene Jiménez, et al.European Journal of Cancer (Oxford, England : 1990)|June 19, 2010
Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumoursHervé Rubie, Birgit Geoerger, Didier Frappaz, et al.European Journal of Cancer (Oxford, England : 1990)|July 25, 2017
Open-label, multicentre, randomised, phase II study of the EpSSG and the ITCC evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients with metastatic soft tissue sarcoma (the BERNIE study)Julia C Chisholm, Johannes H M Merks, Michela Casanova, et al.European Journal of Cancer (Oxford, England : 1990)|September 24, 2016
Prognostic factors of overall survival in children and adolescents enrolled in dose-finding trials in Europe: An Innovative Therapies for Children with Cancer studyFernando Carceller, Francisco J Bautista, Irene Jiménez, et al.Neuro-Oncology|June 13, 2017
Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastomaMark W Kieran, Julia Chisholm, Michela Casanova, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2017
A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid TumorsBirgit Geoerger, Franck Bourdeaut, Steven G DuBois, et al.JCO Precision Oncology|July 15, 2026
Erdafitinib in Patients With Advanced Solid Tumors With FGFR Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary CohortsOmar Carranza, Shubham Pant, Martin Schuler, et al.Neuro-Oncology|October 27, 2010
Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumorsBirgit Geoerger, Darren Hargrave, Fabienne Thomas, et al.Pageof 19